Please login to the form below
biologic
This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.
AZ says target of $45bn sales by 2023 still achievable
patient prescriptions in the US and Germany and topping all biologics for asthma on that measure in Japan.
Latest news
-
Novartis: pipeline will generate 60 filings in three years
Also in that category and in late-stage clinical development are CRTH2 antagonist QAW039 (fevipiprant) for moderate-to-severe asthma – which it says combines the efficacy of new biologic drugs with
-
Dupixent helps put Sanofi back on growth track
Approval is asthma could help drive sales of the drug above the $7.5bn mark, according to Leerink analysts, as it is the only asthma biologic that patients can self-administer
-
Amgen CEO says Aimovig is “one of most successful launches”
As biosimilars start to eat into sales of its blockbuster biologic drugs, Amgen needs new products to deliver growth – and it says migraine therapy Aimovig is off to a great start.
-
Novartis gains label boost for Cosentyx
The boost was based on 24-week structural disease progression data from FUTURE 5, which became the largest phase 3 study for a biologic conducted in PsA to date.
-
China’s Innovent to start US trials of anti-CD47 cancer drug
Sintilimab will be initially positioned for the Chinese market. Chinese biotech Innovent Biologics has been given approval by the FDA to start trials of an antibody that targets CD47, an emerging
More from news
Approximately 20 fully matching, plus 587 partially matching documents found.
Latest Intelligence
-
Nudge-nudge, think-think
The power of achieving the triad of capability, opportunity and peer endorsement is evidenced by a recent study into how to avoid retrograde outcomes when switching patients from biologics to biosimilars.
-
Making Europe a leader in bioscience: boosting trust and opening minds
New disruptive innovation is changing the way we create value in healthcare: big data, artificial intelligence, the growing role of patients, the discovery of new materials and biologics, gene, cell and
-
AstraZeneca: building a new ‘open innovation’ pharma company
and biologics housed under the same roof. ... Co-locating scientists who work on chemistry and small molecule drug development with scientists who work on biologics, large molecules and protein based therapeutics, in lab-based environments for the first
-
Cancer immunotherapy: What's on the horizon?
targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year
-
Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?
In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets.
More from intelligence
Approximately 2 fully matching, plus 70 partially matching documents found.
Latest appointments
-
BMS appoints CCO, Stephen Davies joins Eisai and more
Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.
-
Industry appointments
Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
-
Nabriva Therapeutics appoints chief medical officer
medical affairs for small molecules and biologics.
-
Ipsen appoints Aidan Murphy as EVP, technical operations
Ipsen appoints Aidan Murphy as EVP, technical operations. He is promoted from senior VP biologics development and manufacturing. ... being senior vice president biologics development and manufacturing.
-
Andy Busch joins Shire as its CSO and head of research and development
both biologics and small molecules.”.
More from appointments
Approximately 7 fully matching, plus 45 partially matching documents found.
Latest from PMHub
-
OUTiCO win Best in UK Pharmaceutical Outsourcing award
OUTiCO win Best in UK Pharmaceutical Outsourcing award. The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months. The Corporate LiveWire Healthcare and Life
-
Pharma and Healthcare Social Media Market Pegged for Robust Expansion During 2015 - 2025
The involvement of regulatory authorities in drafting and issuing guidance for use of interactive media for drugs and biologics proves to be instrumental in deciding the importance of social media marketing ... marketing submissions of interactive
-
Biosurgery Equipment Market Will Reflect Significant Growth Prospects during 2016-2026
The biosurgery includes biologic and synthetic materials that are used during surgery in order to eliminate the complications, improve surgical practices and to meet various surgical needs such as prevent excess
-
Cellbag Bioreactor Chambers Market is Set to Experience Revolutionary Growth by 2027
Cellbag bioreactors are majorly used in bio production process, research and development, process development, and in preclinical trails where small amount of biologics are often required for testing. ... pipeline of biologics of several biotech and
-
Biosimilars And Follow-On Biologics Market: Applications and Global Markets 2016-2026
Biosimilars and Follow-on Biologics Market can be segmented into these following ways:. ... Rheumatoid arthritis. Anemia. Cancer. Diabetes. Others. Segmentation by regions. Biosimilars and Follow-on Biologics Market: Overview .
More from PMHub
Approximately 8 fully matching, plus 50 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Senior Medical Writer
-
Great salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Director
-
Excellent benefits
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Director, Market Access / HEOR - North-West
-
Negotiable
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Medical Writers
-
Competitive Salary and Benefits
-
Account Manager / Account Director
-
Competative
-
Associate Medical Director
-
Highly Competitive
Subscribe to our email news alerts
PMHub
Grace Communications
Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
